DIVIDEND ANNOUNCEMENT: Amgen Inc (NASDAQ:AMGN) on 12/03/2021 declared a dividend of $1.9400 per share

Amgen Inc (NASDAQ:AMGN) on 12/03/2021 declared a dividend of $ 1.9400 per share payable on March 08, 2022 to shareholders of record as of February 15, 2022. Dividend amount recorded is an increase of $ 0.18 from last dividend Paid.

Amgen Inc (NASDAQ:AMGN) has paid dividends since 1997, has a current dividend yield of 3.8645417690% and has increased its dividends for 9 successive years.

Amgen Inc's market cap is $ 113,103,812,800 and has a PE ratio of 20.66. The stock price closed yesterday at $ 200.80 and has a 52 week low/high of $ 198.64 and $ 276.69.

Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co.'s products include: Enbrel® (etanercept), which is used in indications for the treatment of adult patients with moderately to severely active rheumatoid arthritis, patients with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and patients with active psoriatic arthritis; and Prolia® (denosumab), which it is used for the treatment of postmenopausal women with osteoporosis at high risk of fracture or multiple risk factors for fracture; or in patients who have failed or are intolerant to other available osteoporosis therapy.

For more information on Amgen Inc click here.